655 related articles for article (PubMed ID: 23857679)
1. Synthesis of uniform poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) microspheres using a microfluidic chip for comparison.
Yang CH; Huang KS; Grumezescu AM; Wang CY; Tzeng SC; Chen SY; Lin YH; Lin YS
Electrophoresis; 2014 Feb; 35(2-3):316-22. PubMed ID: 23857679
[TBL] [Abstract][Full Text] [Related]
2. Ketotifen-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers: characterization and in vivo evaluation.
Guerrero S; Muñíz E; Teijón C; Olmo R; Teijón JM; Blanco MD
J Pharm Sci; 2008 Aug; 97(8):3153-69. PubMed ID: 18023014
[TBL] [Abstract][Full Text] [Related]
3. Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.
Ekanem EE; Nabavi SA; Vladisavljević GT; Gu S
ACS Appl Mater Interfaces; 2015 Oct; 7(41):23132-43. PubMed ID: 26423218
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
Xinteng Z; Weisan P; Ruhua Z; Feng Z
Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
[TBL] [Abstract][Full Text] [Related]
5. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
[TBL] [Abstract][Full Text] [Related]
6. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
Murty SB; Goodman J; Thanoo BC; DeLuca PP
AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545
[TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.
Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD
Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474
[TBL] [Abstract][Full Text] [Related]
8. Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide).
Matsumoto A; Matsukawa Y; Suzuki T; Yoshino H
J Control Release; 2005 Aug; 106(1-2):172-80. PubMed ID: 15936109
[TBL] [Abstract][Full Text] [Related]
9. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
10. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
[TBL] [Abstract][Full Text] [Related]
11. Use of hydrodynamic flow focusing for the generation of biodegradable camptothecin-loaded polymer microspheres.
Schneider T; Zhao H; Jackson JK; Chapman GH; Dykes J; Häfeli UO
J Pharm Sci; 2008 Nov; 97(11):4943-54. PubMed ID: 18314891
[TBL] [Abstract][Full Text] [Related]
12. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
Ma G
J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique.
Zhu KJ; Jiang HL; Du XY; Wang J; Xu WX; Liu SF
J Microencapsul; 2001; 18(2):247-60. PubMed ID: 11253941
[TBL] [Abstract][Full Text] [Related]
14. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
Kranz H; Ubrich N; Maincent P; Bodmeier R
J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
[TBL] [Abstract][Full Text] [Related]
15. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres.
Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS
J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379
[TBL] [Abstract][Full Text] [Related]
16. Rupture and drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide).
Matsumoto A; Matsukawa Y; Horikiri Y; Suzuki T
Int J Pharm; 2006 Dec; 327(1-2):110-6. PubMed ID: 16971073
[TBL] [Abstract][Full Text] [Related]
17. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
Kim HK; Park TG
J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.
Basarkar A; Devineni D; Palaniappan R; Singh J
Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054
[TBL] [Abstract][Full Text] [Related]
19. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
